%0 Journal Article
%T Advances, opportunities and challenges in developing therapeutic cancer vaccines.
%A Duan Z
%A Yang D
%A Yuan P
%A Dai X
%A Chen G
%A Wu D
%J Crit Rev Oncol Hematol
%V 193
%N 0
%D 2024 Jan 8
%M 37949152
%F 6.625
%R 10.1016/j.critrevonc.2023.104198
%X Therapeutic cancer vaccines have shown promising efficacy in helping immunotherapy for cancer patients, but the systematic characterization of the clinical application and the method for improving efficacy is lacking. Here, we mainly summarize the classification of therapeutic cancer vaccines, including protein vaccines, nucleic acid vaccines, cellular vaccines and anti-idiotypic antibody vaccines, and subdivide the above vaccines according to different types and delivery forms. Additionally, we outline the clinical efficacy and safety of vaccines, as well as the combination strategies of therapeutic cancer vaccines with other therapies. This review will provide a detailed overview and rationale for the future clinical application and development of therapeutic cancer vaccines.